[275] SEQUENCING OF HVRII AND HVRIII OF MITOCHONDRIAL DNA ALLOWS THE DISTINCTION BETWEEN DISSEMINATED AND SYNCHRONIC HEPATOCELLULAR CARCINOMA (HCC)

Ismaïl Labgaa, Carlos Villacorta-Martín, Delia D’Avola, Amanda J. Craig, Johann von Felden, Sebastiao N. Martins‐Filho, Daniela Sia, Ashley Stueck, Stephen C. Ward, Maria Isabel Fiel, Milind Mahajan, Parissa Tabrizian, Swan N. Thung, Celina Ang, Scott L. Friedman, Josep M. Llovet, Myron Schwartz, Augusto Villanueva

Oncogene

Article2001

Chemoembolization improves survival in patients with unresectable hepatocellular carcinoma (HCC)

Josep M. Llovet, María Isabel Real, R. Vilana, Ramón Planas, S. Coll, John J. Aponte, Carmen Ayuso, María Sala, Jordi Muchart, R. Costa, J Rodés, Jordi Bruix

Journal of Hepatology

Letter2012

Next-Generation Sequencing: Path for Driver Discovery in Hepatocellular Carcinoma

S. Toffanin, Helena Cornellà, Andrew Harrington, Josep M. Llovet

Gastroenterology

[275] SEQUENCING OF HVRII AND HVRIII OF MITOCHONDRIAL DNA ALLOWS THE DISTINCTION BETWEEN DISSEMINATED AND SYNCHRONIC HEPATOCELLULAR CARCINOMA (HCC)

Abstract

Discussion(0)

Related publications

Hepatocellular Carcinoma Enters the Sequencing Era

VEGF and iNOS expression in human hepatocellular carcinoma (HCC)

A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinoma

Chemoembolization improves survival in patients with unresectable hepatocellular carcinoma (HCC)

Next-Generation Sequencing: Path for Driver Discovery in Hepatocellular Carcinoma